GnRH agonist for gonadal protection during chemotherapy. 2015

Tommaso Falcone, and Halle C F Moore
Cleveland Clinic Lerner College of Medicine and Obstetrics, Gynecology and Women's Health Institute Cleveland, Cleveland, OH, USA falcont@ccf.org.

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016649 Primary Ovarian Insufficiency Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene. Gonadotropin-Resistant Ovary Syndrome,Ovarian Failure, Premature,Resistant Ovary Syndrome,FMR1-Related Primary Ovarian Insufficiency,Fragile X Premature Ovarian Failure,Fragile X-Associated Primary Ovarian Insufficiency,Hypergonadotropic Ovarian Failure, X-Linked,Premature Ovarian Failure,Premature Ovarian Failure 1,Premature Ovarian Failure, X-Linked,Primary Ovarian Insufficiency, Fragile X-Associated,X-Linked Hypergonadotropic Ovarian Failure,FMR1 Related Primary Ovarian Insufficiency,Fragile X Associated Primary Ovarian Insufficiency,Gonadotropin Resistant Ovary Syndrome,Hypergonadotropic Ovarian Failure, X Linked,Ovarian Insufficiency, Primary,Premature Ovarian Failure, X Linked,Primary Ovarian Insufficiency, Fragile X Associated,X Linked Hypergonadotropic Ovarian Failure

Related Publications

Tommaso Falcone, and Halle C F Moore
August 2009, Fertility and sterility,
Tommaso Falcone, and Halle C F Moore
August 2017, Annals of oncology : official journal of the European Society for Medical Oncology,
Tommaso Falcone, and Halle C F Moore
January 2007, The Kurume medical journal,
Tommaso Falcone, and Halle C F Moore
April 2014, International journal of oncology,
Tommaso Falcone, and Halle C F Moore
April 1997, European journal of endocrinology,
Tommaso Falcone, and Halle C F Moore
May 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Tommaso Falcone, and Halle C F Moore
October 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Tommaso Falcone, and Halle C F Moore
February 2012, Bulletin de l'Academie nationale de medecine,
Tommaso Falcone, and Halle C F Moore
July 1988, Human reproduction (Oxford, England),
Copied contents to your clipboard!